Mina S Ally, MD
Dermatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 4 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
23 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ally’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A144146 · Current
Licensed to practise in California · since 2016 · expires 2028-01-31 · King'S College London School of Medicine at Guy'S, King'S College and St. Thomas' Hospital.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$69,427
Medicare paid this office $69,427 for 244 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 64 | $11,989 | $119 |
| New patient visit (30+ min) | 119 | $11,029 | $93 |
| Short return visit (20+ min) | 98 | $10,857 | $82 |
| Destruction of skin growth, 1-14 growths | 55 | $7,890 | $113 |
| Biopsy of related skin growth, first growth | 59 | $6,595 | $96 |
See all 9 services
| Return visit (30+ min) | 64 | $11,989 | $119 |
| New patient visit (30+ min) | 119 | $11,029 | $93 |
| Short return visit (20+ min) | 98 | $10,857 | $82 |
| Destruction of skin growth, 1-14 growths | 55 | $7,890 | $113 |
| Biopsy of related skin growth, first growth | 59 | $6,595 | $96 |
| Destruction of precancer skin growth, 1 growth | 73 | $5,270 | $52 |
| New patient visit (45+ min) | 32 | $4,580 | $143 |
| Destruction of precancer skin growth, 15 or more growths | 14 | $2,791 | $174 |
| Destruction of precancer skin growth, 2-14 growths | 62 | $2,597 | $7 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 508 | More than 87% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 134 | More than 79% of doctors who do this |
Who their Medicare patients are
244 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 16% · Women 65% · Also on Medicaid 11% · Health risk score 0.88. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 55% · Diabetes 19% · Depression 17% · Coronary heart disease 16% · Cancer 16% · Chronic kidney disease 13% · Atrial fibrillation 11% · Heart failure 9% · COPD 7% · Stroke 6%.
The office billed $246,541, Medicare allowed $93,742 and paid $69,427; for 1,246 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 244 | 1,246 | 75 | 0.88 | $246,541 | $69,427 |
| 2023 | 249 | 870 | 70 | 1.83 | $390,350 | $32,993 |
| 2022 | 256 | 882 | 70 | 1.52 | $422,283 | $36,461 |
| 2021 | 208 | 583 | 68 | 1.68 | $235,246 | $23,135 |
| 2020 | 160 | 454 | 67 | 1.81 | $199,551 | $18,905 |
| 2019 | 232 | 676 | 69 | 1.54 | $273,533 | $24,013 |
| 2018 | 125 | 308 | 67 | 1.32 | $90,945 | $9,795 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 144 | $16,923 | $71 |
| Destruction of precancer skin growth, 1 growth | 51 | $3,011 | $42 |
| New patient visit (30+ min) | 46 | $2,669 | $58 |
| New patient visit (45+ min) | 20 | $1,925 | $96 |
| Short return visit (20+ min) | 37 | $1,759 | $45 |
| Biopsy of related skin growth, first growth | 43 | $1,140 | $22 |
| Destruction of skin growth, 1-14 growths | 22 | $929 | $40 |
| Destruction of precancer skin growth, 2-14 growths | 36 | $564 | $2 |
| Punch biopsy, first skin growth | 11 | $385 | $35 |
2022: 10 services
| Return visit (30+ min) | 122 | $14,393 | $77 |
| Short return visit (20+ min) | 101 | $5,777 | $50 |
| Destruction of precancer skin growth, 1 growth | 55 | $3,192 | $44 |
| New patient visit (30+ min) | 34 | $1,804 | $53 |
| Destruction of skin growth, 1-14 growths | 27 | $1,780 | $57 |
| Biopsy of related skin growth, first growth | 47 | $1,282 | $21 |
| Punch biopsy, first skin growth | 17 | $740 | $37 |
| Biopsy of related skin growth, each additional growth | 17 | $492 | $20 |
| Destruction of precancer skin growth, 2-14 growths | 36 | $439 | $2 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $300 | $21 |
2021: 10 services
| Return visit (30+ min) | 72 | $6,568 | $79 |
| Short return visit (20+ min) | 69 | $4,169 | $53 |
| Destruction of precancer skin growth, 1 growth | 38 | $2,007 | $45 |
| Telephone medical discussion with physician, 5-10 minutes | 49 | $1,697 | $27 |
| Destruction of skin growth, 1-14 growths | 24 | $1,485 | $57 |
| New patient visit (30+ min) | 12 | $831 | $69 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $777 | $65 |
| Biopsy of related skin growth, first growth | 25 | $669 | $23 |
| Short return visit | 16 | $495 | $31 |
| Destruction of precancer skin growth, 2-14 growths | 25 | $294 | $2 |
2020: 10 services
| Return visit (30+ min) | 54 | $4,670 | $67 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $1,536 | $43 |
| Short return visit (20+ min) | 28 | $1,393 | $45 |
| Destruction of precancer skin growth, 1 growth | 18 | $1,177 | $49 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,152 | $72 |
| Destruction of skin growth, 1-14 growths | 13 | $825 | $55 |
| Telephone medical discussion with physician, 5-10 minutes | 29 | $670 | $19 |
| Biopsy of related skin growth, first growth | 22 | $653 | $24 |
| Short return visit | 14 | $311 | $22 |
| Destruction of precancer skin growth, 2-14 growths | 17 | $194 | $2 |
2019: 10 services
| Return visit (30+ min) | 75 | $6,947 | $63 |
| Short return visit (20+ min) | 81 | $3,321 | $34 |
| Destruction of precancer skin growth, 1 growth | 43 | $2,168 | $40 |
| New patient visit (30+ min) | 34 | $1,548 | $46 |
| Destruction of skin growth, 1-14 growths | 25 | $1,378 | $51 |
| New patient visit (15+ min) | 47 | $1,362 | $29 |
| Biopsy of related skin growth, first growth | 37 | $884 | $23 |
| Destruction of precancer skin growth, 2-14 growths | 33 | $343 | $2 |
| Short return visit | 13 | $273 | $21 |
| Biopsy of related skin growth, each additional growth | 12 | $248 | $17 |
2018: 7 services
| Short return visit (20+ min) | 58 | $2,703 | $43 |
| New patient visit (15+ min) | 40 | $1,738 | $43 |
| Destruction of precancer skin growth, 1 growth | 28 | $1,272 | $45 |
| New patient visit (30+ min) | 17 | $851 | $50 |
| Biopsy of single growth of skin and/or tissue | 23 | $804 | $35 |
| Return visit (30+ min) | 11 | $762 | $63 |
| Destruction of precancer skin growth, 2-14 growths | 23 | $211 | $2 |
Medicaid work
$21,455 in 2023
Medicaid paid $21,455 for 2,180 billed services this clinician did in 2023, up to 132 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,138 | $9,693 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 295 | $4,645 |
| New patient visit (30+ min) | 156 | $1,933 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 90 | $1,704 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 108 | $1,351 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 102 | $1,050 |
| Short return visit (20+ min) | 163 | $905 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 30 | $174 |
| Service | 15 | $0 |
| Injection, intralesional; up to and including 7 lesions | 12 | $0 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 71 | $0 |
| 2023 | 2,180 | 11 | 132 | $21,455 |
| 2022 | 1,799 | 9 | 97 | $18,421 |
| 2021 | 1,396 | 10 | 98 | $23,712 |
| 2020 | 986 | 7 | 59 | $43,930 |
| 2019 | 2,064 | 11 | 72 | $35,190 |
| 2018 | 708 | 9 | 68 | $4,040 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 748 | $5,853 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 170 | $3,353 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 205 | $2,950 |
| Short return visit (20+ min) | 427 | $2,488 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 73 | $1,721 |
| New patient visit (30+ min) | 110 | $1,589 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 41 | $425 |
| Injection, intralesional; up to and including 7 lesions | 13 | $41 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 12 | $0 |
2021
| Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | 147 | $12,325 |
| Short return visit (20+ min) | 569 | $3,110 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 99 | $3,094 |
| Return visit (30+ min) | 412 | $3,031 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 26 | $935 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 24 | $378 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 37 | $364 |
| New patient visit (30+ min) | 51 | $287 |
| Short return visit | 14 | $132 |
| Injection, intralesional; up to and including 7 lesions | 17 | $55 |
2020
| Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | 312 | $26,520 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 243 | $12,501 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 158 | $1,542 |
| Online evaluation and management service provided by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient or guardian, not originating from a related E/M service provided within the previous 7 days, using the Internet or similar electronic communications network | 17 | $1,445 |
| Return visit (30+ min) | 138 | $1,247 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 53 | $343 |
| Short return visit (20+ min) | 65 | $332 |
2019
| Online evaluation and management service provided by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient or guardian, not originating from a related E/M service provided within the previous 7 days, using the Internet or similar electronic communications network | 250 | $20,230 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 213 | $5,312 |
| Return visit (30+ min) | 511 | $3,362 |
| Short return visit (20+ min) | 423 | $1,365 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 184 | $1,060 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 80 | $1,052 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 155 | $1,008 |
| New patient visit (30+ min) | 96 | $877 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 28 | $600 |
| Short return visit | 112 | $270 |
| Injection, intralesional; up to and including 7 lesions | 12 | $55 |
2018
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 94 | $1,145 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 147 | $819 |
| Short return visit (20+ min) | 225 | $673 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 30 | $533 |
| Return visit (30+ min) | 103 | $432 |
| Service | 51 | $270 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 28 | $133 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 16 | $30 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 14 | $4 |
Drugs they prescribed that Part D paid
$418,553
Pharmacies billed $418,553 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 531) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
455 generic and 76 brand-name prescriptions · $418,553 in drug cost · 15 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira | 12 | $116,853 | $9,738 |
| Dupixent | 16 | $58,525 | $3,658 |
| Tacrolimus | 16 | $2,550 | $159 |
| Betamethasone Diprop Augmented | 25 | $2,086 | $83 |
| Fluorouracil | 30 | $2,050 | $68 |
See all 12 drugs
| Humira | 12 | $116,853 | $9,738 |
| Dupixent | 16 | $58,525 | $3,658 |
| Tacrolimus | 16 | $2,550 | $159 |
| Betamethasone Diprop Augmented | 25 | $2,086 | $83 |
| Fluorouracil | 30 | $2,050 | $68 |
| Fluocinonide | 38 | $976 | $26 |
| Triamcinolone Acetonide | 83 | $936 | $11 |
| Ketoconazole | 48 | $692 | $14 |
| Mupirocin | 51 | $376 | $7 |
| Hydrocortisone | 57 | $244 | $4 |
| Nystatin | 15 | $184 | $12 |
| Hydroxyzine | 12 | $146 | $12 |
Year by year
| 2024 | 531 | 220 | 0% (0) | 14% | $418,553 |
| 2023 | 1,677 | 291 | 0% (0) | 31% | $2,799,475 |
| 2022 | 1,347 | 283 | 0% (0) | 25% | $1,652,491 |
| 2021 | 897 | 241 | 0% (0) | 24% | $951,543 |
| 2020 | 833 | 243 | 0% (0) | 21% | $707,989 |
| 2019 | 871 | 240 | 0% (0) | 24% | $585,893 |
| 2018 | 266 | 114 | None | 22% | $114,684 |
| 2017 | 56 | 24 | None | 20% | $47,487 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Humira | 96 | $856,061 | $8,917 |
| Dupixent | 133 | $500,114 | $3,760 |
| Stelara | 15 | $363,368 | $24,225 |
| Taltz | 35 | $266,897 | $7,626 |
| Otezla | 16 | $113,953 | $7,122 |
| Cosentyx Sensoready (2 Pens) | 14 | $104,696 | $7,478 |
| Humira | 12 | $88,990 | $7,416 |
| Dupixent | 23 | $84,451 | $3,672 |
| Acitretin | 19 | $15,803 | $832 |
| Betamethasone Diprop Augmented | 91 | $10,834 | $119 |
| Fluocinonide | 141 | $7,433 | $53 |
| Tacrolimus | 55 | $7,282 | $132 |
| Fluorouracil | 39 | $5,837 | $150 |
| Triamcinolone Acetonide | 174 | $3,646 | $21 |
| Ketoconazole | 135 | $2,448 | $18 |
| Calcipotriene | 23 | $2,065 | $90 |
| Clobetasol Propionate | 44 | $2,034 | $46 |
| Fluocinolone Acetonide | 24 | $1,811 | $75 |
| Hydroxyzine | 75 | $1,376 | $18 |
| Doxycycline Monohydrate | 21 | $1,298 | $62 |
| Mycophenolate Mofetil | 22 | $1,257 | $57 |
| Clindamycin Phosphate | 36 | $1,219 | $34 |
| Clotrimazole | 37 | $1,072 | $29 |
| Methotrexate | 20 | $663 | $33 |
| Hydrocortisone | 99 | $650 | $7 |
| Mupirocin | 58 | $557 | $10 |
| Dexamethasone | 17 | $426 | $25 |
| Nystatin | 12 | $255 | $21 |
| Prednisone | 24 | $203 | $8 |
2022: 24 drugs
| Humira | 98 | $620,748 | $6,334 |
| Stelara | 15 | $298,274 | $19,885 |
| Taltz | 26 | $202,684 | $7,796 |
| Humira | 17 | $117,209 | $6,895 |
| Dupixent | 15 | $51,145 | $3,410 |
| Dupixent | 12 | $27,870 | $2,322 |
| Acitretin | 21 | $14,915 | $710 |
| Betamethasone Diprop Augmented | 116 | $14,243 | $123 |
| Fluocinonide | 128 | $8,975 | $70 |
| Fluorouracil | 31 | $4,368 | $141 |
| Tacrolimus | 29 | $3,584 | $124 |
| Triamcinolone Acetonide | 178 | $3,238 | $18 |
| Calcipotriene | 21 | $2,587 | $123 |
| Ketoconazole | 105 | $2,071 | $20 |
| Clotrimazole | 36 | $1,649 | $46 |
| Clindamycin Phosphate | 30 | $1,482 | $49 |
| Hydroxyzine | 62 | $1,025 | $17 |
| Dexamethasone | 18 | $816 | $45 |
| Clobetasol Propionate | 15 | $815 | $54 |
| Methotrexate | 22 | $781 | $36 |
| Hydrocortisone | 108 | $738 | $7 |
| Doxycycline Monohydrate | 30 | $665 | $22 |
| Mupirocin | 56 | $471 | $8 |
| Prednisone | 14 | $120 | $9 |
2021: 19 drugs
| Humira | 57 | $374,425 | $6,569 |
| Humira | 18 | $108,818 | $6,045 |
| Betamethasone Diprop Augmented | 96 | $12,546 | $131 |
| Fluocinonide | 77 | $5,262 | $68 |
| Tacrolimus | 18 | $3,113 | $173 |
| Triamcinolone Acetonide | 127 | $2,062 | $16 |
| Betamethasone Dipropionate | 15 | $1,848 | $123 |
| Fluorouracil | 18 | $1,801 | $100 |
| Clobetasol Propionate | 20 | $1,693 | $85 |
| Clindamycin Phosphate | 37 | $1,544 | $42 |
| Methotrexate | 25 | $1,206 | $48 |
| Ketoconazole | 70 | $1,075 | $15 |
| Metronidazole | 14 | $1,035 | $74 |
| Hydrocortisone | 74 | $494 | $7 |
| Doxycycline Monohydrate | 17 | $399 | $23 |
| Hydroxyzine | 33 | $224 | $7 |
| Azathioprine | 11 | $189 | $17 |
| Prednisone | 11 | $129 | $12 |
| Mupirocin | 22 | $118 | $5 |
2020: 20 drugs
| Humira | 28 | $231,284 | $8,260 |
| Humira | 21 | $156,749 | $7,464 |
| Betamethasone Diprop Augmented | 65 | $9,032 | $139 |
| Acitretin | 12 | $7,764 | $647 |
| Fluocinonide | 83 | $5,670 | $68 |
| Calcipotriene | 13 | $2,896 | $223 |
| Betamethasone Dipropionate | 18 | $2,444 | $136 |
| Triamcinolone Acetonide | 146 | $2,323 | $16 |
| Fluorouracil | 17 | $2,203 | $130 |
| Metronidazole | 23 | $1,925 | $84 |
| Methotrexate | 16 | $1,301 | $81 |
| Doxycycline Hyclate | 11 | $1,110 | $101 |
| Clindamycin Phosphate | 37 | $1,070 | $29 |
| Hydrocortisone | 69 | $601 | $9 |
| Ketoconazole | 30 | $480 | $16 |
| Doxycycline Monohydrate | 17 | $333 | $20 |
| Hydroxyzine | 29 | $271 | $9 |
| Azathioprine | 12 | $245 | $20 |
| Mupirocin | 19 | $131 | $7 |
| Gabapentin | 13 | $56 | $4 |
2019: 22 drugs
| Humira | 34 | $234,747 | $6,904 |
| Humira | 23 | $135,187 | $5,878 |
| Dupixent | 13 | $38,030 | $2,925 |
| Acitretin | 23 | $17,233 | $749 |
| Betamethasone Diprop Augmented | 67 | $8,155 | $122 |
| Fluocinonide | 89 | $6,299 | $71 |
| Calcipotriene | 14 | $4,029 | $288 |
| Fluorouracil | 27 | $3,032 | $112 |
| Metronidazole | 25 | $2,206 | $88 |
| Triamcinolone Acetonide | 111 | $2,039 | $18 |
| Tretinoin | 11 | $1,794 | $163 |
| Ketoconazole | 54 | $1,224 | $23 |
| Hydroxychloroquine Sulfate | 13 | $1,113 | $86 |
| Mycophenolate Mofetil | 16 | $1,035 | $65 |
| Clindamycin Phosphate | 27 | $971 | $36 |
| Doxycycline Monohydrate | 18 | $695 | $39 |
| Methotrexate | 16 | $638 | $40 |
| Hydrocortisone | 72 | $530 | $7 |
| Hydroxyzine | 13 | $337 | $26 |
| Azathioprine | 12 | $305 | $25 |
| Mupirocin | 21 | $233 | $11 |
| Prednisone | 12 | $114 | $10 |
2018: 8 drugs
| Humira | 13 | $73,547 | $5,657 |
| Betamethasone Diprop Augmented | 19 | $1,887 | $99 |
| Fluocinonide | 27 | $1,864 | $69 |
| Fluorouracil | 11 | $1,274 | $116 |
| Retin-A | 13 | $959 | $74 |
| Triamcinolone Acetonide | 33 | $802 | $24 |
| Ketoconazole | 18 | $512 | $28 |
| Hydrocortisone | 22 | $221 | $10 |
2017: 1 drug
| Ketoconazole | 15 | $440 | $29 |
Money from drug and device companies
$3,383 in 2025
| 2025 | 17 | 137 | None | $3,383 |
| 2024 | 16 | 83 | None | $2,193 |
| 2023 | 3 | 4 | None | $272 |
| 2020 | 1 | 1 | $230 | $230 |
| 2019 | 1 | 1 | None | $97 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Galderma Laboratories L.P. | Nemluvio | $450 | 16 payments
|
| Janssen Biotech | Tremfya | $383 | 14 payments
|
| Incyte | Opzelura | $349 | 19 payments
|
| Abbvie | Skyrizi | $325 | 14 payments
|
| Regeneron Healthcare Solutions | Dupixent | $316 | 14 payments
|
| Lilly USA | Taltz | $270 | 10 payments
|
See all 137 published payments
| Sun Pharmaceutical Industries | Meals · 2025-12-23 | Ilumya | $33 |
| Incyte | Meals · 2025-12-22 | Opzelura | $20 |
| Genzyme | Meals · 2025-12-22 | Dupixent | $37 |
| Regeneron Healthcare Solutions | Education · 2025-12-18 | Dupixent | $5 |
| Incyte | Meals · 2025-12-11 | Opzelura | $17 |
| Galderma Laboratories L.P. | Meals · 2025-12-10 | Nemluvio | $42 |
| Abbvie | Meals · 2025-12-09 | Skyrizi | $22 |
| Galderma Laboratories L.P. | Meals · 2025-12-03 | Nemluvio | $15 |
| Novartis Pharmaceuticals | Meals · 2025-12-01 | Cosentyx | $20 |
| Incyte | Meals · 2025-11-26 | Opzelura | $29 |
| Arcutis Biotherapeutics | Meals · 2025-11-25 | Zoryve | $15 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-11-24 | Cabtreo | $22 |
| Galderma Laboratories L.P. | Meals · 2025-11-19 | Nemluvio | $36 |
| Janssen Biotech | Meals · 2025-11-18 | Tremfya | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-11-18 | Dupixent | $27 |
| Genzyme | Meals · 2025-11-12 | Dupixent | $35 |
| LEO Pharma | Meals · 2025-11-11 | Anzupgo | $22 |
| Ucb | Meals · 2025-11-04 | Bimzelx | $5 |
| Ucb | Meals · 2025-11-04 | Bimzelx | $30 |
| Arcutis Biotherapeutics | Meals · 2025-11-04 | Zoryve | $25 |
| Incyte | Meals · 2025-10-30 | Opzelura | $29 |
| Janssen Biotech | Meals · 2025-10-27 | Tremfya | $26 |
| Incyte | Meals · 2025-10-22 | Opzelura | $2 |
| Incyte | Meals · 2025-10-22 | Opzelura | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-21 | Cosentyx | $25 |
| Abbvie | Meals · 2025-10-16 | Rinvoq | $17 |
| Incyte | Meals · 2025-10-15 | Opzelura | $7 |
| Janssen Biotech | Meals · 2025-10-14 | Tremfya | $22 |
| Incyte | Meals · 2025-10-14 | Opzelura | $21 |
| LEO Pharma | Meals · 2025-10-13 | Adbry | $22 |
| Abbvie | Meals · 2025-10-10 | Skyrizi | $22 |
| Sun Pharmaceutical Industries | Meals · 2025-10-08 | Ilumya | $34 |
| Sun Pharmaceutical Industries | Meals · 2025-10-08 | Ilumya | $2 |
| Galderma Laboratories L.P. | Meals · 2025-10-07 | Nemluvio | $40 |
| Genzyme | Meals · 2025-10-01 | Dupixent | $30 |
| LEO Pharma | Meals · 2025-09-29 | Anzupgo | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-09-25 | Dupixent | $26 |
| Abbvie | Meals · 2025-09-23 | Rinvoq | $13 |
| Abbvie | Meals · 2025-09-23 | Rinvoq | $20 |
| Abbvie | Meals · 2025-09-23 | Skyrizi | $33 |
| Galderma Laboratories L.P. | Meals · 2025-09-22 | Nemluvio | $10 |
| Pfizer | Meals · 2025-09-18 | Cibinqo | $26 |
| Arcutis Biotherapeutics | Meals · 2025-09-18 | Zoryve | $13 |
| Ucb | Meals · 2025-09-16 | Bimzelx | $32 |
| Incyte | Meals · 2025-09-16 | Opzelura | $18 |
| Janssen Biotech | Meals · 2025-09-09 | Tremfya | $42 |
| Lilly USA | Meals · 2025-09-08 | Taltz | $28 |
| Abbvie | Meals · 2025-09-03 | Rinvoq | $30 |
| Sun Pharmaceutical Industries | Meals · 2025-09-02 | Winlevi | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-08-28 | Dupixent | $27 |
| Incyte | Meals · 2025-08-26 | Opzelura | $29 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-08-20 | Cabtreo | $25 |
| Novartis Pharmaceuticals | Meals · 2025-08-18 | Cosentyx | $28 |
| Novartis Pharmaceuticals | Meals · 2025-08-18 | Cosentyx | $28 |
| LEO Pharma | Meals · 2025-08-05 | Adbry | $28 |
| Arcutis Biotherapeutics | Meals · 2025-07-30 | Zoryve | $24 |
| Janssen Biotech | Meals · 2025-07-29 | Tremfya | $32 |
| Lilly USA | Meals · 2025-07-29 | Taltz | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-07-29 | Dupixent | $12 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-07-28 | Cabtreo | $24 |
| Organon | Meals · 2025-07-28 | None | $21 |
| Incyte | Meals · 2025-07-24 | Opzelura | $7 |
| Galderma Laboratories L.P. | Meals · 2025-07-22 | Nemluvio | $25 |
| Lilly USA | Meals · 2025-07-21 | Taltz | $30 |
| Genzyme | Meals · 2025-07-16 | Dupixent | $29 |
| Abbvie | Meals · 2025-07-15 | Skyrizi | $28 |
| Arcutis Biotherapeutics | Meals · 2025-07-14 | Zoryve | $10 |
| Pfizer | Meals · 2025-07-11 | Cibinqo | $27 |
| Galderma Laboratories L.P. | Meals · 2025-07-03 | Nemluvio | $32 |
| Regeneron Healthcare Solutions | Meals · 2025-07-02 | Dupixent | $27 |
| Amgen | Meals · 2025-06-26 | Otezla | $14 |
| Abbvie | Meals · 2025-06-25 | Rinvoq | $30 |
| Arcutis Biotherapeutics | Meals · 2025-06-23 | Zoryve | $13 |
| Janssen Biotech | Meals · 2025-06-20 | Tremfya | $19 |
| Janssen Biotech | Meals · 2025-06-18 | Tremfya | $39 |
| Lilly USA | Meals · 2025-06-17 | Taltz | $35 |
| Incyte | Meals · 2025-06-12 | Opzelura | $19 |
| Incyte | Meals · 2025-06-11 | Opzelura | $3 |
| Lilly USA | Meals · 2025-06-09 | Taltz | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-06-05 | Dupixent | $27 |
| Incyte | Meals · 2025-06-03 | Opzelura | $25 |
| Galderma Laboratories L.P. | Meals · 2025-06-03 | Nemluvio | $30 |
| Abbvie | Meals · 2025-06-02 | Rinvoq | $9 |
| Lilly USA | Meals · 2025-05-29 | Taltz | $25 |
| Genzyme | Meals · 2025-05-28 | Dupixent | $35 |
| Regeneron Healthcare Solutions | Meals · 2025-05-22 | Dupixent | $19 |
| Pfizer | Meals · 2025-05-20 | Cibinqo | $22 |
| Lilly USA | Meals · 2025-05-19 | Taltz | $27 |
| Janssen Biotech | Meals · 2025-05-13 | Tremfya | $19 |
| Lilly USA | Meals · 2025-05-09 | Taltz | $8 |
| Abbvie | Meals · 2025-05-09 | Skyrizi | $52 |
| Galderma Laboratories L.P. | Meals · 2025-05-08 | Nemluvio | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-04-30 | Libtayo | $34 |
| Galderma Laboratories L.P. | Meals · 2025-04-30 | Nemluvio | $25 |
| Arcutis Biotherapeutics | Meals · 2025-04-28 | Zoryve | $21 |
| Janssen Biotech | Meals · 2025-04-16 | Tremfya | $34 |
| Genzyme | Meals · 2025-04-16 | Dupixent | $24 |
| Ucb | Meals · 2025-04-15 | Bimzelx | $34 |
| Galderma Laboratories L.P. | Meals · 2025-04-09 | Nemluvio | $29 |
| Incyte | Meals · 2025-04-08 | Opzelura | $31 |
| Pfizer | Meals · 2025-04-04 | Cibinqo | $24 |
| Janssen Biotech | Meals · 2025-04-02 | Tremfya | $24 |
| Arcutis Biotherapeutics | Meals · 2025-04-01 | Zoryve | $18 |
| Novartis Pharmaceuticals | Meals · 2025-03-26 | Cosentyx | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-03-26 | Dupixent | $16 |
| Incyte | Meals · 2025-03-26 | Opzelura | $17 |
| Incyte | Meals · 2025-03-26 | Opzelura | $2 |
| Arcutis Biotherapeutics | Meals · 2025-03-20 | Zoryve | $15 |
| Galderma Laboratories L.P. | Meals · 2025-03-13 | Nemluvio | $38 |
| Janssen Biotech | Meals · 2025-03-11 | Tremfya | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-03-11 | Dupixent | $26 |
| Incyte | Meals · 2025-03-07 | Opzelura | $23 |
| Genzyme | Meals · 2025-03-05 | Dupixent | $34 |
| Lilly USA | Meals · 2025-03-04 | Taltz | $21 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-02-27 | Dupixent | $27 |
| Abbvie | Education · 2025-02-26 | Skyrizi | $10 |
| Galderma Laboratories L.P. | Meals · 2025-02-26 | Nemluvio | $13 |
| Galderma Laboratories L.P. | Meals · 2025-02-25 | Nemluvio | $19 |
| Sun Pharmaceutical Industries | Meals · 2025-02-25 | Winlevi | $36 |
| Genzyme | Meals · 2025-02-18 | Dupixent | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-02-13 | Dupixent | $17 |
| Incyte | Meals · 2025-02-12 | Opzelura | $27 |
| Novartis Pharmaceuticals | Meals · 2025-02-07 | Cosentyx | $18 |
| Lilly USA | Meals · 2025-02-05 | Taltz | $35 |
| Galderma Laboratories L.P. | Meals · 2025-02-05 | Nemluvio | $39 |
| Ucb | Meals · 2025-02-04 | Bimzelx | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-01-28 | Dupixent | $27 |
| Organon | Meals · 2025-01-28 | Vtama | $32 |
| Arcutis Biotherapeutics | Meals · 2025-01-22 | Zoryve | $21 |
| Janssen Biotech | Meals · 2025-01-21 | Tremfya | $29 |
| Janssen Biotech | Meals · 2025-01-15 | Tremfya | $19 |
| Abbvie | Meals · 2025-01-15 | Skyrizi | $8 |
| Janssen Biotech | Meals · 2025-01-14 | Tremfya | $33 |
| Ucb | Meals · 2025-01-13 | Bimzelx | $39 |
| Galderma Laboratories L.P. | Meals · 2025-01-08 | Nemluvio | $28 |
| Sanofi-Aventis U.S. | Education · 2025-01-06 | Dupixent | $80 |
See earlier years (2024, 2023, 2020, 2019)
2024: $2,193
| Janssen Biotech | Tremfya | $517 | 16 payments
|
| Abbvie | Skyrizi | $295 | 9 payments
|
| Regeneron Healthcare Solutions | Dupixent | $252 | 11 payments
|
| Incyte | Opzelura | $219 | 10 payments
|
| Pfizer | Eucrisa | $139 | 8 payments
|
| Sun Pharmaceutical Industries | Ilumya | $135 | 5 payments
|
| Novartis Pharmaceuticals | Cosentyx | $109 | 4 payments
|
| Genzyme | Dupixent | $106 | 3 payments
|
| Lilly USA | Taltz | $104 | 4 payments
|
| Arcutis Biotherapeutics | Zoryve | $83 | 4 payments
|
| Ucb | Bimzelx | $65 | 2 payments
|
| LEO Pharma | Adbry | $58 | 2 payments
|
| Galderma Laboratories L.P. | None | $44 | 2 payments
|
| Dermavant Sciences | Vtama | $31 | 1 payment
|
| Amgen | Otezla | $21 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Cabtreo | $15 | 1 payment
|
2023: $272
| E.R. Squibb & Sons L.L.C. | Sotyktu | $132 | 2 payments
|
| AbbVie | Skyrizi | $125 | 1 payment
|
| Pfizer | Cibinqo | $15 | 1 payment
|
2020: $230
| LEO Pharma AS | None | $230 | 1 payment
|
2019: $97
| Allergan | None | $97 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1528467099
- Licence
- CA 144146California A144146: Current · expires 2028-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2014-08-20
- NPI last updated
- 2024-03-06
- NPI record certified
- 2024-03-06
This is when the NPI record was last certified, not a medical board exam.